High BAALC expression associates with other molecular prognostic markers, poor outcome and a distinct gene expression signature in cytogenetically normal acute myeloid leukemia (CN AML): A Cancer and Leukemia Group B (CALGB) study

被引：0
|
作者：
Langer, C.
Ruppert, A. S.
Radmacher, M. D.
Whitman, S. P.
Paschka, P.
Baldus, C. D.
Mrozek, K.
Kolitz, J. E.
Marcucci, G.
Bloomfield, C. D.
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Charite Campus Benjamin Franklin, Berlin, Germany
[3] North Shore Univ Hosp, Manhasset, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7013
引用
收藏
页数：2
相关论文
共 50 条
  • [31] IDH1 AND IDH2 GENE MUTATIONS IDENTIFY NOVEL MOLECULAR SUBSETS WITHIN DE NOVO CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (CN-AML): A CANCER AND LEUKEMIA GROUP B (CALGB) STUDY
    Marcucci, G.
    Maharry, K.
    Wu, Y. Z.
    Radmacher, M.
    Mrozek, K.
    Margeson, D.
    Holland, K.
    Whitman, S.
    Becker, H.
    Schwind, S.
    Metzeler, K.
    Powell, B.
    Carter, T.
    Kolitz, J.
    Wetzler, M.
    Baer, M.
    Carroll, A.
    Caligiuri, M.
    Larson, R.
    Bloomfield, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 456 - 456
  • [32] Increased Expression of Macrophage Migration Inhibitory Factor (MIF) Receptor CD74 Is Associated with Inferior Outcome in Younger Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML): a Cancer and Leukemia Group B (CALGB) Study.
    Attar, Eyal C.
    Maharry, Kati
    Mrozek, Krzysztof
    Radmacher, Michael D.
    Whitman, Susan P.
    Paschka, Peter
    Langer, Christian
    Holland, Kelsi B.
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Carroll, Andrew J.
    Larson, Richard A.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2009, 114 (22) : 645 - 646
  • [33] Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia
    Walker, Christopher J.
    Mrozek, Krzysztof
    Ozer, Hatice Gulcin
    Nicolet, Deedra
    Kohlschmidt, Jessica
    Papaioannou, Dimitrios
    Genutis, Luke K.
    Bill, Marius
    Powell, Bayard L.
    Uy, Geoffrey L.
    Kolitz, Jonathan E.
    Carroll, Andrew J.
    Stone, Richard M.
    Garzon, Ramiro
    Byrd, John C.
    Eisfeld, Ann-Kathrin
    de la Chapelle, Albert
    Bloomfield, Clara D.
    BLOOD ADVANCES, 2021, 5 (05) : 1474 - 1482
  • [34] Higher MN1 expression is an unfavorable prognosticator in older patients (Pts) with cytogenetically normal acute myeloid leukemia (CN-AML): A CALGB study
    Schwind, Sebastian
    Marcucci, Guido
    Holland, Kelsi B.
    Mrozek, Krzysztof
    Michael, Radmacher D.
    Maharry, Kati
    Becker, Heiko
    Whitman, Susan P.
    Wu, Yue-Zhong
    Carter, Thomas H.
    Powell, Bayard L.
    Caligiuri, Michael A.
    Baer, Maria R.
    Larson, Richard A.
    Bloomfield, Clara D.
    CANCER RESEARCH, 2010, 70
  • [35] BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia
    S Weber
    T Alpermann
    F Dicker
    S Jeromin
    N Nadarajah
    C Eder
    A Fasan
    A Kohlmann
    M Meggendorfer
    C Haferlach
    W Kern
    T Haferlach
    S Schnittger
    Blood Cancer Journal, 2014, 4 : e173 - e173
  • [36] A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia
    Metzeler, K. H.
    Maharry, K.
    Kohlschmidt, J.
    Volinia, S.
    Mrozek, K.
    Becker, H.
    Nicolet, D.
    Whitman, S. P.
    Mendler, J. H.
    Schwind, S.
    Eisfeld, A-K
    Wu, Y-Z
    Powell, B. L.
    Carter, T. H.
    Wetzler, M.
    Kolitz, J. E.
    Baer, M. R.
    Carroll, A. J.
    Stone, R. M.
    Caligiuri, M. A.
    Marcucci, G.
    Bloomfield, C. D.
    LEUKEMIA, 2013, 27 (10) : 2023 - 2031
  • [37] A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia
    K H Metzeler
    K Maharry
    J Kohlschmidt
    S Volinia
    K Mrózek
    H Becker
    D Nicolet
    S P Whitman
    J H Mendler
    S Schwind
    A-K Eisfeld
    Y-Z Wu
    B L Powell
    T H Carter
    M Wetzler
    J E Kolitz
    M R Baer
    A J Carroll
    R M Stone
    M A Caligiuri
    G Marcucci
    C D Bloomfield
    Leukemia, 2013, 27 : 2023 - 2031
  • [38] BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia
    Weber, S.
    Alpermann, T.
    Dicker, F.
    Jeromin, S.
    Nadarajah, N.
    Eder, C.
    Fasan, A.
    Kohlmann, A.
    Meggendorfer, M.
    Haferlach, C.
    Kern, W.
    Haferlach, T.
    Schnittger, S.
    BLOOD CANCER JOURNAL, 2014, 4 : e173 - e173
  • [39] Adverse Prognostic Impact of GAS6 Expression in De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (CALGB 8461, 9665, 20202; Alliance)
    Whitman, Susan
    Kohlschmidt, Jessica
    Maharry, Kati
    Nicolet, Deedra
    Schwind, Sebastian
    Becker, Heiko
    Metzeler, Klaus H.
    Mrozek, Krzysztof
    Mendler, Jason H.
    Eisfeld, Ann-Kathrin
    Volinia, Stefano
    Powell, Bayard L.
    Carter, Thomas H.
    Kolitz, Jonathan E.
    Stone, Richard M.
    Park, Il-Kyoo
    Caligiuri, Michael A.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2012, 120 (21)
  • [40] High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia:: A Cancer and Leukemia Group B study
    Marcucci, Guido
    Maharry, Kati
    Whitman, Susan P.
    Vukosavljevic, Tamara
    Paschka, Peter
    Langer, Christian
    Mrozek, Krzysztof
    Baldus, Claudia D.
    Carroll, Andrew J.
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Larson, Richard A.
    Bloomfield, Clara D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3337 - 3343
12345